Donor's graft ex vivo T-cell depletion with fludarabine reduces graft-versus-host disease signs and improves survival after intestinal transplantation - an experimental study.

Transplant International : Official Journal of the European Society for Organ Transplantation
Maria VelaAntonio Pérez-Martínez

Abstract

Intestinal passenger T leukocytes are responsible for graft-versus-host disease (GvHD) in intestinal transplantation (ITx). We hypothesized that ex vivo fludarabine treatment of the bowel graft would diminish the risk of GvHD and improve overall survival post-transplant. We performed isolated heterotopic small bowel transplantations from Lewis (LEW) to Brown Norway (BN) rat strains, which generated GvHD signs from the fourth day post-transplant. These symptoms included rash, weight loss, piloerection, and diarrhea. The grafts of one of the experimental groups were immersed and sealed in cold Celsior preservation solution with 1000 µm fludarabine for 1 h, prior to its implantation into recipient animals. No histological signs of intestinal tissue alterations were observed after fludarabine treatment. Fludarabine-treated bowel recipients showed significantly later and milder clinical signs of GvHD and reduced total donor cell chimerism, as determined by flow cytometry using strain-specific anti-HLA antibodies. Additionally, fludarabine treatment prolonged recipients' overall survival (13.5 days ± 0.3 days vs. 9.2 days ± 0.5). We conclude that active modification of the intestinal leukocyte composition is advantageous in our ITx a...Continue Reading

References

Apr 1, 1987·Journal of Immunogenetics·G W Butcher
Apr 30, 2003·Transplantation·Tong WuA Jake Demetris
Nov 12, 2003·Biochemical Pharmacology·Romina GamberaleMirta Giordano
Aug 17, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·George V MazariegosJorge Reyes
Dec 12, 2007·European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Für Kinderchirurgie·T PintarA Pleskovic
Feb 16, 2010·Journal of Pediatric Surgery·Ane M AndresJuan Antonio Tovar
Apr 27, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sue Pondrom
Sep 11, 2012·Pediatric Dermatology·Marta Feito-RodríguezEsther Ramos Boluda
Dec 3, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D GrantUNKNOWN Intestinal Transplant Association
May 21, 2016·Pediatric Transplantation·Thomas Green, Jonathan Hind
Jun 29, 2017·American Journal of Clinical Dermatology·Karla Strong RodriguesRobert Knobler

❮ Previous
Next ❯

Citations

Jan 5, 2021·Current Opinion in Organ Transplantation·Mihai Oltean

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.